A study showed that oral FAP-DNA vaccine could induce both CD8+ and CD4+ immune responses, and antitumor immunity was enhanced by combing FAP DNA vaccine with other tumor antigen-specific DNA vaccines (98). This evidence concerns the gene CD8A and neoplasm.